Patents by Inventor Gerd Schluckebier

Gerd Schluckebier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060258561
    Abstract: This invention relates to NPH-insulin (crystalline preparations) that are prepared in the presence of certain high-affinity ligands for the HisB10 Zn2+-sites of the R-state insulin hexamer. Preparation of NPH-insulin in the presence of high-affinity ligand results in crystalline NPH-insulin suspensions that are absorbed more slowly from subcutis than regular NPH-insulin.
    Type: Application
    Filed: September 9, 2005
    Publication date: November 16, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Per Balschmidt, Helle Olsen, Niels Kaarsholm, Peter Madsen, Palle Jakobsen, Svend Ludvigsen, Gerd Schluckebier, Dorte Steensgaard, Anders Petersen
  • Publication number: 20060069013
    Abstract: Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.
    Type: Application
    Filed: September 12, 2005
    Publication date: March 30, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Soren Ostergaard, Helle Olsen, Niels Kaarsholm, Peter Madsen, Palle Jakobsen, Svend Ludvigsen, Gerd Schluckebier, Dorte Steensgaard, Anders Petersen
  • Publication number: 20050065066
    Abstract: The present invention provides pharmaceutical compositions comprising insulin and novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The resulting preparations have improved physical and chemical stability.
    Type: Application
    Filed: April 16, 2004
    Publication date: March 24, 2005
    Inventors: Niels Kaarsholm, Peter Madsen, Morten Schlein, Helle Olsen, Svend Havelund, Dorte Steensgaard, Svend Ludvigsen, Palle Jakobsen, Anders Petersen, Gerd Schluckebier